Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Affiliations

• ¹ Department I Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Dusseldorf, University of Cologne, Cologne, Germany.
• ² Department of Hematology, Medical University of Lodz, Copernicus Memorial Hospital, Lodz, Poland.
• ³ Institute of Hematology and Oncology, Department of Hematology, Hospital Clinic, University of Barcelona, Barcelona, Spain.
• ⁴ Strategic Research Program on CLL, Division of Experimental Oncology, Università Vita-Salute San Raffaele and IRCCS Ospedale San Raffaele, Milano, Italy.
• ⁵ Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
• ⁶ Department of Hematology, Cancer Center Amsterdam, Lymphoma and Myeloma Center Amsterdam, LYMMCARE, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
• ⁷ Hematology, Luzerner Kantonsspital, Luzern, Switzerland.
• ⁸ Hematology Biology, Hôpital Avicenne, Assistance Publique Hopitaux de Paris, UMR U978 INSERM, Bobigny, France.
• ⁹ Institute of Experimental Cancer Research, Comprehensive Cancer Center, University Hospital of Ulm, Ulm, Germany.
• ¹⁰ Leeds Institute of Medical Research, University of Leeds, St James's University Hospital, Leeds, UK.
• ¹¹ Department I Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Dusseldorf, University of Cologne, Cologne, Germany; Center of Excellence on Cellular Stress Responses in Aging-Associated Diseases, University of Cologne, Cologne, Germany.
• ¹² Department of Oncology and Haematology, Kantonsspital Graubuenden, Chur, Switzerland.